Recomb partner, Sheba published an article on a Large Cohort of RAG1/2-Deficient SCID Patients
Article about gene therapy in de Volkskrant
January 21, 2020Successful Preclinical Development of Gene Therapy for RAG1-SCID
April 28, 2020Recomb partner, Sheba published an article on a Large Cohort of RAG1/2-Deficient SCID Patients
An article has recently been published by one of the Recomb partners, Sheba in the Journal of Clinical Immunology where they presented the clinical, immunological, and prognostic analysis of a large cohort of RAG1/2-Deficient SCID Patients. The authors emphasized the importance of immediate precautions, an urge for curative treatment and the implementation of the newborn screening for SCID. Read the article here.
